The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic associations of the G8 geriatric screening tool in the EORTC Brain Tumor Group trials 1608 and 1709 in patients with newly diagnosed glioblastoma.
 
Michael Weller
Consulting or Advisory Role - AstraZeneca (I); Bayer (I); Biodexa (I); Curevac; Hemerion; Janssen (I); LEO Pharma (I); Medac; Medac (I); Novartis; Novartis; Novartis (I); Orbus Therapeutics; Pfizer (I); Philogen; Roche (I); Sandoz; Seagen (I); Seagen (I); Servier; Servier (I)
Research Funding - BMS (Inst); Novartis (Inst)
 
Luc Boone
No Relationships to Disclose
 
Patrick Roth
Honoraria - Merck; Novocure; Roche
Consulting or Advisory Role - Alexion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; CDR-Life; Debiopharm Group; Desitin Pharma; Galapagos NV; Laminar Pharma; Midatech Pharma; MSD; NEURAXPHARM; OM Pharma; QED Therapeutics; Sanofi; SERVIER
Research Funding - MSD (Inst); Novocure (Inst); TME Pharma (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Matthias Preusser
No Relationships to Disclose
 
Lissandra Dal Lago
Travel, Accommodations, Expenses - Novartis; Roche
 
Paolo Bossi
Honoraria - BeiGene; Daiichi-Sankyo; Genmab/Seagen; GlaxoSmithKline; LEO Pharma; Merck; Merus; MSD Oncology; Nutricia; Pfizer; Regeneron; Sun Pharma
Consulting or Advisory Role - Daiichi-Sankyo; Genmab/Seagen; GlaxoSmithKline; Merck Serono; MSD Oncology; Nutricia; Sanofi/Regeneron; Sun Pharma
Research Funding - AstraZeneca (Inst); BeiGene (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); Merus NV (Inst); MSD Oncology (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Merck Serono
 
Warren Mason
Honoraria - Novocure; Servier
Consulting or Advisory Role - Deciphera; GlaxoSmithKline; Novocure; Ono Pharmaceutical
 
Thierry Gorlia
No Relationships to Disclose
 
Murielle Mauer
No Relationships to Disclose
 
Emilie Le Rhun
Honoraria - Bayer (I); Novocure (I)
Consulting or Advisory Role - AstraZeneca; Biodexa Pharmaceuticals; CureVac (I); Leo Pharma; Medac; Medac (I); My Tomorrows; My Tomorrows (I); Novartis; Novartis (I); Orbus Therapeutics (I); Pfizer; Philogen (I); Roche; Roche (I); Sandoz (I); Seagen; SERVIER; SERVIER (I)
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Quercegen Pharmaceuticals (Inst); Servier (Inst); Versameb (Inst)